Clinical Trial

Probiotics in Alleviating Microplastic-Induced Obesity

Completed
View on ClinicalTrials.gov →
Summary
The study attempts to conduct randomized double-blind controlled trials to understand whether daily exposure to microplastics (MPs) can cause potential impacts on human health, explore whether the intake of Lactiplantibacillus plantarum PD01 can alleviate potential obesity-related damages caused by MPs, and provide a scientific basis for the prevention and nutritional intervention of health hazards caused by MP exposure.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-10.
Trial Details
NCT Number NCT07416214
Lead Sponsor Fudan University
Collaborators: Xiamen Yueyi Biotechnology Co., Ltd.
Conditions Intestinal Functional Disorder, Inflammation
Enrollment 96 participants
Start Date 2025-11-30
Primary Completion 2026-01-12 (estimated)
Study Completion 2026-02-10 (estimated)
Updated on ClinicalTrials.gov 2026-02-25